Julia Guzmán-Puche

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros et al. · Journal of Antimicrobial Chemotherapy · 2019 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

Ángela Cano, Belén Gutiérrez‐Gutiérrez, Isabel Machuca et al. · Clinical Infectious Diseases · 2017 · 110 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

Miquel Àngel Sastre-Femenía, Almudena Fernández-Muñoz, María A. Gomis-Font et al. · The Lancet Regional Health - Europe · 2023 · 82 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

Isabel Machuca, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger et al. · Antimicrobial Agents and Chemotherapy · 2017 · 76 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17